Postprostatectomy Radiation Therapy for Prostate Cancer

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Radical prostatectomy is the most common initial treatment for prostate cancer. Patients with high-risk pathologic features, such as a positive margin or seminal vesicle involvement, have a 40% to 50% risk of developing biochemical failure at some point in the future. Radiotherapy to the prostate bed has been used both adjuvantly and for salvage. There continues to be an active debate regarding when radiation should be administered, although 3 recent randomized trials show a consistent improvement in biochemical failure when adjuvant radiotherapy is administered as compared with radical prostatectomy alone. Because the morbidity of postoperative radiotherapy is relatively low, when pathologic high risk factors are present adjuvant radiotherapy should be considered. The role of androgen deprivation postprostatectomy is less well defined.

Original languageEnglish
Pages (from-to)15-22
Number of pages8
JournalSeminars in Radiation Oncology
Volume18
Issue number1
DOIs
StatePublished - Jan 1 2008
Externally publishedYes

Fingerprint

Adjuvant Radiotherapy
Prostatectomy
radiation therapy
Prostatic Neoplasms
Radiotherapy
cancer
Seminal Vesicles
Androgens
Prostate
Radiation
deprivation
Morbidity
beds
margins
radiation
Therapeutics

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology
  • Radiation

Cite this

Postprostatectomy Radiation Therapy for Prostate Cancer. / Abramowitz, Matthew C; Pollack, Alan.

In: Seminars in Radiation Oncology, Vol. 18, No. 1, 01.01.2008, p. 15-22.

Research output: Contribution to journalArticle

@article{375b85f2150345e68b8dda1a95d275f4,
title = "Postprostatectomy Radiation Therapy for Prostate Cancer",
abstract = "Radical prostatectomy is the most common initial treatment for prostate cancer. Patients with high-risk pathologic features, such as a positive margin or seminal vesicle involvement, have a 40{\%} to 50{\%} risk of developing biochemical failure at some point in the future. Radiotherapy to the prostate bed has been used both adjuvantly and for salvage. There continues to be an active debate regarding when radiation should be administered, although 3 recent randomized trials show a consistent improvement in biochemical failure when adjuvant radiotherapy is administered as compared with radical prostatectomy alone. Because the morbidity of postoperative radiotherapy is relatively low, when pathologic high risk factors are present adjuvant radiotherapy should be considered. The role of androgen deprivation postprostatectomy is less well defined.",
author = "Abramowitz, {Matthew C} and Alan Pollack",
year = "2008",
month = "1",
day = "1",
doi = "10.1016/j.semradonc.2007.09.003",
language = "English",
volume = "18",
pages = "15--22",
journal = "Seminars in Radiation Oncology",
issn = "1053-4296",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Postprostatectomy Radiation Therapy for Prostate Cancer

AU - Abramowitz, Matthew C

AU - Pollack, Alan

PY - 2008/1/1

Y1 - 2008/1/1

N2 - Radical prostatectomy is the most common initial treatment for prostate cancer. Patients with high-risk pathologic features, such as a positive margin or seminal vesicle involvement, have a 40% to 50% risk of developing biochemical failure at some point in the future. Radiotherapy to the prostate bed has been used both adjuvantly and for salvage. There continues to be an active debate regarding when radiation should be administered, although 3 recent randomized trials show a consistent improvement in biochemical failure when adjuvant radiotherapy is administered as compared with radical prostatectomy alone. Because the morbidity of postoperative radiotherapy is relatively low, when pathologic high risk factors are present adjuvant radiotherapy should be considered. The role of androgen deprivation postprostatectomy is less well defined.

AB - Radical prostatectomy is the most common initial treatment for prostate cancer. Patients with high-risk pathologic features, such as a positive margin or seminal vesicle involvement, have a 40% to 50% risk of developing biochemical failure at some point in the future. Radiotherapy to the prostate bed has been used both adjuvantly and for salvage. There continues to be an active debate regarding when radiation should be administered, although 3 recent randomized trials show a consistent improvement in biochemical failure when adjuvant radiotherapy is administered as compared with radical prostatectomy alone. Because the morbidity of postoperative radiotherapy is relatively low, when pathologic high risk factors are present adjuvant radiotherapy should be considered. The role of androgen deprivation postprostatectomy is less well defined.

UR - http://www.scopus.com/inward/record.url?scp=36849076704&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36849076704&partnerID=8YFLogxK

U2 - 10.1016/j.semradonc.2007.09.003

DO - 10.1016/j.semradonc.2007.09.003

M3 - Article

C2 - 18082584

AN - SCOPUS:36849076704

VL - 18

SP - 15

EP - 22

JO - Seminars in Radiation Oncology

JF - Seminars in Radiation Oncology

SN - 1053-4296

IS - 1

ER -